On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayMay 29, 2009 5:05 am

Explorations Group, Inc. (EXGI.OB) Appoints Robert McCann as New President and CEO

Explorations Group, Inc., a provider of biometrically based security solutions, recently announced the appointment of Robert E. McCann III as their new President and CEO. Upon the appointment of Mr. McCann, the company's previous President, David Coriaty, became their Executive Chairman. From January 2008 to May 2009, Mr. McCann served as Chairman and Chief Executive Officer of Revolution Forward Consulting Group, a business transformation consulting company. Prior to that position, McCann worked on Wall Street for 14 years as a licensed broker, Investment Advisor Representative, and General Securities Principal. Additionally, Mr. McCann served as a Board Member of a NASDAQ…

Continue Reading

FridayMay 29, 2009 4:54 am

IR BioSciences Holdings, Inc. (IRBS.OB) Subsidiary Announces IND Submission for Homspera® for the Treatment of Idiopathic Pulmonary Fibrosis

ImmuneRegen BioSciences, a development-stage biotechnology company and a wholly owned subsidiary of IR BioSciences Holdings, Inc. (IRBS.OB), announced the company’s submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) to begin human clinical testing of Homspera® for the treatment of Idiopathic Pulmonary Fibrosis. Currently afflicting 5 million people worldwide and killing 40,000 people annually, Idiopathic Pulmonary Fibrosis is a progressive interstitial lung disease characterized by scarring of lung tissue and over time prevents the lung from effectively transferring oxygen into the bloodstream. Homspera® is an adult stem cell active compound that has shown…

Continue Reading

ThursdayMay 28, 2009 1:16 pm

Wataire International, Inc. (WTAR.OB) is “One to Watch”

Wataire International, Inc. is a development stage company with corporate headquarters in Woodland Hills, California. They engage in the marketing and distribution of commercial and home/office atmospheric water generation machines in the United States. Trading on NASDAQ's OTCBB, the Company is part of the Diversified Machinery industry in the Industrial Goods sector. Wataire's target customers include businesses, governments, and people situated in the humid tropics around the world. The Company also owns intellectual property relating to a water treatment process and devices for water-from-air machines. Wataire International has identified high-potential applications for Atmospheric Water Generators (AWGs) in 10 different markets.…

Continue Reading

ThursdayMay 28, 2009 12:25 pm

Suspect Detection Systems Inc.’s (SDSS.OB) COGITO Technology is at the Forefront of Home Land Security and Defense

Suspect Detection Systems Inc. (SDSS.OB) develops various technology solutions for homeland security, military intelligence and law enforcement. The company was created by former Israeli security officials and experts who use their combined knowledge and intelligence of counter-terrorism gained in Israel and other parts of the world to develop security technologies. One of the company’s first products is COGITO, a fully automated system used to scope out various settings and scenarios to identify malicious activity or intent. This innovative system works on its own, without human control or operation, to conduct interrogations that might otherwise take hundreds of man-hours. COGITO uses…

Continue Reading

ThursdayMay 28, 2009 10:20 am

BWI Holdings, Inc. (BWIH.OB) Reports Profitable Period Despite Economy

BWI Holdings, Inc., the small but growing Canadian based waste collection and processing company, has shown a remarkable ability to generate profit in spite of one of the worst economic downturns in memory. While many far larger companies have been scrambling just to remain in business, BWI continues to make money, moving forward toward its goal of becoming the #1 waste solution partner in North America. One of the obvious strengths of the company is the simple fact that people require basic waste collection even in bad times. But commercial and industrial operations have been cutting back and closing their…

Continue Reading

ThursdayMay 28, 2009 10:07 am

UpTurn Inc. (UPTR.PK): Social Networking and the Real Estate Market

The UpTurn Inc. is developing an innovative online real estate matchmaking exchange and social networking site where real estate market participants are matched with each other, based on their individual profiles and intended roles in the market. The company's site serves would-be buyers and sellers, real estate professionals, and others. The UpTurn was started by M.I.T. Sloan Business School graduate Jeff Eckman. Mr. Eckman founded Blue Green Ventures in 2008 after 15 years of experience in the technology, media, and healthcare industries. This groundbreaking venture – The UpTurn – has established a Web 2.0 real estate business model. The company…

Continue Reading

ThursdayMay 28, 2009 6:52 am

Power Medical Interventions® (PMII.OB) Receives 510(k) Clearance to Market iDrive Intelligent Power Unit™ with iConsole™

Power Medical Interventions®, Inc. (PMII.OB), the world's only provider of computer-assisted, power-actuated surgical cutting and stapling products, announced yesterday that the company has received clearance from the U.S. Food and Drug Administration (FDA) for its 510(k) application for marketing iDrive Intelligent Power Unit™, a detachable Intelligent Surgical Instruments and iConsole™. As a leader in developing and commercializing Intelligent Surgical Instruments™, Power Medical Interventions intends to launch the iDrive, Intelligent Surgical Instruments and iConsole products for commercial sale, effective immediately. The iDrive is designed to support a variety of minimally invasive procedures by offering surgeons a broad range of cutting configurations…

Continue Reading

ThursdayMay 28, 2009 6:08 am

Cytori Therapeutics (CYTX) Announces Publication of Cardiovascular Preclinical Study

Cytori Therapeutics announced today before the opening bell that the first preclinical study to demonstrate adipose-derived stem and regenerative cells (ADRCs) significantly improved cardiac function after a heart attack has been published. This preclinical study was reported online ahead of print in the International Journal of Cardiology. Funded by Cytori Therapeutics, the study was conducted at Tulane University. “Treatment of cardiovascular disease, which places one of the greatest burdens on our healthcare system, could be revolutionized by cell therapy,” stated Marc H. Hedrick, M.D., president of Cytori. “We observed a statistically significant improvement in heart function that contributed to our…

Continue Reading

ThursdayMay 28, 2009 5:47 am

Sector 10, Inc. (SECI.OB) Appoints Director of Business Development

Sector 10, Inc. announced today that it has appointed Mr. Patrick B. Love to Director of Business Development. In his new position, Mr. Love will serve as the primary external contact for Sector 10 in Business Development. He will be working with both the investor and lending communities and will report to the Chief Operations Officer. In addition, Mr. Love will be focusing on introducing new technologies, methodologies, and strategies with partner companies that he will be identifying and establishing relationships with. He has already begun working with Sector 10 in formulating a 5-year Business Development Strategic Plan and believes…

Continue Reading

ThursdayMay 28, 2009 5:34 am

Energtek Inc. (EGTK.PK) Announces First of $1.5M Investment by EGFE DM Ltd.

Energtek Inc., a world leader in the development of Adsorbed Natural Gas (ANG) technology, announced this morning that it has received the first installment of a $1,500,000 USD investment agreement recently signed with EGFE DM Ltd. The $150,000 tranche is the first of ten such tranches to take place over the next 12 months. Under the terms of the Letter of Intent signed by the two companies, Energtek will grant EGFE restricted shares of common stock in return for the investment. The investment of each tranche will take place at $0.30 per share or at a ten percent discount on…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered